Works matching AU Ge, Shuai-Shuai

Results: 8

Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification.

Published in:

2024

By:

Wan, Chao-Ling;
Liu, Yu-Qing;
Liu, Fang-Tong;
Huang, Yuan-Hong;
Cao, Han-Yu;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Wang, Miao;
Liu, Mei-Jing;
Wang, Zi-Hao;
Li, Zheng;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Letter

Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00982-3

By:

Li, Yan-Yan;
Ge, Shuai-Shuai;
Huang, Yuan-Hong;
Xu, Ming-Zhu;
Wan, Chao-Ling;
Tan, Kai-Wen;
Tao, Tao;
Zhou, Hai-Xia;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Article

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00948-x

By:

Wang, Miao;
Cao, Han-Yu;
Tan, Kai-Wen;
Qiu, Qiao-Cheng;
Huang, Yuan-Hong;
Ge, Shuai-shuai;
Wang, Zi-Hao;
Chen, Jia;
Tang, Xiao-Wen;
Wu, De-Pei;
Xue, Sheng-Li;
Li, Zheng;
Dai, Hai-Ping

Publication type:

Article

A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.797941

By:

Wang, Bin-Ru;
Wan, Chao-Ling;
Liu, Song-Bai;
Qiu, Qiao-Cheng;
Wu, Tian-Mei;
Wang, Jun;
Li, Yan-Yan;
Ge, Shuai-Shuai;
Qiu, Yan;
Shen, Xiang-Dong;
Xue, Sheng-Li;
Li, Zheng

Publication type:

Article

Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation.

Published in:

Annals of Hematology, 2024, v. 103, n. 12, p. 6003, doi. 10.1007/s00277-024-06137-5

By:

Liu, Fang-Tong;
Wan, Chao-Ling;
Huang, Yuan-Hong;
Cao, Han-Yu;
Lyu, Xiao-Yu;
Wang, Zi-Hao;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Zhang, Yang;
Xue, Sheng-Li

Publication type:

Article

Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.841276

By:

Li, Zheng;
Wang, Jun;
Ge, Shuai-Shuai;
Qiu, Qiao-Cheng;
Du, Jia-Hui;
Shan, Shuang-Shuang;
Shen, Xiang-Dong;
Wan, Chao-Ling;
Wang, Bin-Ru;
Wu, De-Pei;
Qiu, Hui-Ying;
Xue, Sheng-Li

Publication type:

Article

Mutation spectrum of FLT3 and significance of non‐canonical FLT3 mutations in haematological malignancy.

Published in:

British Journal of Haematology, 2023, v. 202, n. 3, p. 539, doi. 10.1111/bjh.18877

By:

Ge, Shuai‐Shuai;
Qiu, Qiao‐Cheng;
Dai, Hai‐Ping;
Shen, Xiang‐Dong;
Wu, Tian‐Mei;
Du, Jia‐Hui;
Wan, Chao‐Ling;
Shen, Hong‐Jie;
Wu, De‐Pei;
Xue, Sheng‐Li;
Liu, Song‐Bai

Publication type:

Article

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report.

Published in:

2023

By:

Huang, Si‐Man;
Tao, Tao;
Wan, Chao‐Ling;
Wu, Tian‐Mei;
Cao, Han‐Yu;
Qiu, Yan;
Shen, Xiang‐Dong;
Wang, Bin‐Ru;
Ge, Shuai‐Shuai;
Li, Yan‐Yan;
Zhang, Tong‐Tong;
Wu, Bing;
Xue, Sheng‐Li

Publication type:

Case Study